List of COVID-19 simulation models

Last updated

COVID-19 simulation models are mathematical infectious disease models for the spread of COVID-19. [1] The list should not be confused with COVID-19 apps used mainly for digital contact tracing.

Contents

Note that some of the applications listed are website-only models or simulators, and some of those rely on (or use) real-time data from other sources.

Models with the most scientific backing

The sub-list contains simulators that are based on theoretical models. Due to the high number of pre-print research created and driving by the COVID-19 pandemic, [2] especially newer models should only be considered with further scientific rigor. [3] [4]

Simulations and models

Genome databases

Several of these models make use of genome databases, including the following:

Consortia, research clusters, other collections

Vaccination monitors, models or dashboards

Note: The following (additional) resources are mostly based on actual data, not simulation. They might include predictive features, e. g. vaccination rate estimation, but in general are not based on theoretical or modeling grounds as the main list of this article. Nonetheless, forecasting remains important. [64] (See for example the COVID-19 Forecast Hub) [65]

Models with less scientific backing

The following models are purely for educational purposes only.

Trainings and other resources

See also

Related Research Articles

<span class="mw-page-title-main">SARS</span> Disease caused by severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

<span class="mw-page-title-main">Alessandro Vespignani</span> Italian-American physicist (born 1965)

Alessandro Vespignani is an Italian-American physicist, best known for his work on complex networks, and particularly for work on the applications of network theory to the mathematical modeling of infectious disease, applications of computational epidemiology, and for studies of the topological properties of the Internet. He is currently the Sternberg Family Distinguished University Professor of Physics, Computer Science and Health Sciences at Northeastern University, where he is the director of the Network Science Institute.

<span class="mw-page-title-main">Social distancing</span> Infection control technique by keeping a distance from each other

In public health, social distancing, also called physical distancing, is a set of non-pharmaceutical interventions or measures intended to prevent the spread of a contagious disease by maintaining a physical distance between people and reducing the number of times people come into close contact with each other. It usually involves keeping a certain distance from others and avoiding gathering together in large groups.

<span class="mw-page-title-main">Airborne transmission</span> Disease transmission by airborne particles

Airborne transmission or aerosol transmission is transmission of an infectious disease through small particles suspended in the air. Infectious diseases capable of airborne transmission include many of considerable importance both in human and veterinary medicine. The relevant infectious agent may be viruses, bacteria, or fungi, and they may be spread through breathing, talking, coughing, sneezing, raising of dust, spraying of liquids, flushing toilets, or any activities which generate aerosol particles or droplets.

<span class="mw-page-title-main">Superspreading event</span> Event in which 3 or more people attend and an infectious disease is spread much more than usual

A superspreading event (SSEV) is an event in which an infectious disease is spread much more than usual, while an unusually contagious organism infected with a disease is known as a superspreader. In the context of a human-borne illness, a superspreader is an individual who is more likely to infect others, compared with a typical infected person. Such superspreaders are of particular concern in epidemiology.

<span class="mw-page-title-main">COVID-19 pandemic</span> Pandemic caused by SARS-CoV-2

The COVID-19 pandemic, also known as the coronavirus pandemic, is a global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in an outbreak in Wuhan, the capital of Hubei, China, in December 2019, before it spread to other areas of Asia, and then worldwide in early 2020. The World Health Organization (WHO) declared the outbreak a public health emergency of international concern (PHEIC) on 30 January 2020, and assessed the outbreak had become a pandemic on 11 March 2020. The WHO ended the PHEIC on 5 May 2023. As of 28 April 2024, the pandemic has caused 7,045,569 confirmed deaths, making it the fifth-deadliest pandemic or epidemic in history.

<span class="mw-page-title-main">SARS-CoV-2</span> Virus that causes COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

<span class="mw-page-title-main">COVID-19 testing</span> Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

<span class="mw-page-title-main">COVID-19 pandemic in the Central African Republic</span> Ongoing COVID-19 viral pandemic in the Central African Republic

The COVID-19 pandemic in the Central African Republic was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic was confirmed to have reached the Central African Republic in March 2020.

The COVID-19 pandemic in Chad was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Chad in March 2020. As the third least developed nation in the world, according to the HDI in 2019, Chad has faced unique economic, social, and political challenges under the strain of the COVID-19 pandemic.

The COVID-19 pandemic in São Tomé and Príncipe is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached São Tomé and Príncipe on 6 April 2020. The first death was recorded on 30 April.

<span class="mw-page-title-main">Symptoms of COVID-19</span> Overview of the symptoms of COVID-19

The symptoms of COVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness. Common symptoms include coughing, fever, loss of smell (anosmia) and taste (ageusia), with less common ones including headaches, nasal congestion and runny nose, muscle pain, sore throat, diarrhea, eye irritation, and toes swelling or turning purple, and in moderate to severe cases, breathing difficulties. People with the COVID-19 infection may have different symptoms, and their symptoms may change over time. Three common clusters of symptoms have been identified: one respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; and a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. In people without prior ear, nose, or throat disorders, loss of taste combined with loss of smell is associated with COVID-19 and is reported in as many as 88% of symptomatic cases.

CovidSim is an epidemiological model for COVID-19 developed by Imperial College COVID-19 Response Team, led by Neil Ferguson. The Imperial College study addresses the question: If complete suppression is not feasible, what is the best strategy combining incomplete suppression and control that is feasible and leads to acceptable outcomes?

<span class="mw-page-title-main">Transmission of COVID-19</span> Mechanisms that spread coronavirus disease 2019

The transmission of COVID-19 is the passing of coronavirus disease 2019 from person to person. COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

<span class="mw-page-title-main">Variants of SARS-CoV-2</span> Notable variants of SARS-CoV-2

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.

Nextstrain is a collaboration between researchers in Seattle, United States and Basel, Switzerland which provides a collection of open-source tools for visualising the genetics behind the spread of viral outbreaks.

<span class="mw-page-title-main">SARS-CoV-2 variant of concern</span> Highly transmissible and virulent strains of SARS-CoV-2

The term variant of concern (VOC) for SARS-CoV-2, which causes COVID-19, is a category used for variants of the virus where mutations in their spike protein receptor binding domain (RBD) substantially increase binding affinity in RBD-hACE2 complex, while also being linked to rapid spread in human populations.

<span class="mw-page-title-main">Nirmatrelvir</span> COVID-19 antiviral medication

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of a nirmatrelvir/ritonavir combination used to treat COVID-19 and sold under the brand name Paxlovid.

References

  1. ↑ Adam D (April 2020). "Special report: The simulations driving the world's response to COVID-19". Nature. 580 (7803): 316–318. Bibcode:2020Natur.580..316A. doi:10.1038/d41586-020-01003-6. PMID   32242115. S2CID   256820433.
  2. ↑ Brierley L. "The role of research preprints in the academic response to the COVID-19 epidemic". Authorea Preprints. doi: 10.22541/au.158516578.89167184 .
  3. ↑ "Another 178,000 deaths? Scientists' latest virus projection is a warning". NBC News. 24 September 2020. Retrieved 2021-02-22.
  4. ↑ Tufekci Z (2020-04-02). "Don't Believe the COVID-19 Models". The Atlantic. Retrieved 2021-02-22.
  5. ↑ Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L (February 2020). "A mathematical model for simulating the phase-based transmissibility of a novel coronavirus". Infectious Diseases of Poverty. 9 (1): 24. doi: 10.1186/s40249-020-00640-3 . PMC   7047374 . PMID   32111262.
  6. ↑ "CoSim Online". shiny.covid-simulator.com. Retrieved 14 December 2023.
  7. ↑ "COVID-19 Mobility Network Modeling". covid-mobility.stanford.edu. Retrieved 14 December 2023.
  8. ↑ Chang S, Pierson E, Koh PW, Gerardin J, Redbird B, Grusky D, Leskovec J (January 2021). "Mobility network models of COVID-19 explain inequities and inform reopening". Nature. 589 (7840): 82–87. Bibcode:2021Natur.589...82C. doi: 10.1038/s41586-020-2923-3 . PMID   33171481.
  9. ↑ "Home - COVID-19 Simulator". covid19sim.org. Retrieved 14 December 2023.
  10. ↑ "Policy Simulator Methodology". COVID-19 Simulator. Retrieved 2021-02-21.
  11. ↑ "Healthcare Workers". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 14 December 2023.
  12. ↑ CDC (2020-02-11). "Healthcare Workers". Centers for Disease Control and Prevention. Retrieved 2021-02-22.
  13. ↑ Ng MK. "SEIRS-based COVID-19 Simulation Package". markusng.com. Retrieved 14 December 2023.
  14. ↑ "Research project - CovidSim - Modeling and simulation of covid infection spread in crowds in system relevant infrastructures - HM Hochschule München University of Applied Sciences". Hochschule München. Retrieved 14 December 2023.
  15. ↑ Ng M (24 September 2023). "COVIDSim — SEIRS-based COVID-19 Simulation Package". GitHub . Retrieved 14 December 2023.
  16. ↑ Ng M (2020-12-23), nkymark/COVIDSim , retrieved 2021-03-09
  17. ↑ Ng KY, Gui MM (October 2020). "COVID-19: Development of a robust mathematical model and simulation package with consideration for ageing population and time delay for control action and resusceptibility". Physica D: Nonlinear Phenomena. 411: 132599. arXiv: 2004.01974 . Bibcode:2020PhyD..41132599N. doi:10.1016/j.physd.2020.132599. PMC   7282799 . PMID   32536738.
  18. ↑ "CovidSIM". covidsim.eu. Retrieved 2021-03-13.
  19. ↑ Schneider KA, Ngwa GA, Schwehm M, Eichner L, Eichner M (November 2020). "The COVID-19 pandemic preparedness simulation tool: CovidSIM". BMC Infectious Diseases. 20 (1): 859. doi: 10.1186/s12879-020-05566-7 . PMC   7675392 . PMID   33213360.
  20. ↑ "CovRadar". covradar.net. Retrieved 14 December 2023.
  21. ↑ Wittig A, Miranda F, Hölzer M, Altenburg T, Bartoszewicz JM, Dieckmann MA, et al. (2021-04-06). "CovRadar: Continuously tracking and filtering SARS-CoV-2 mutations for molecular surveillance". bioRxiv   10.1101/2021.02.03.429146v2 .
  22. ↑ "Molecular surveillance of SARS-CoV-2 spike protein mutations using CovRadar". News-Medical.net. 2021-02-07. Retrieved 2021-04-25.
  23. ↑ De-Leon H, Pederiva F (August 2020). "Particle modeling of the spreading of coronavirus disease (COVID-19)". Physics of Fluids. 32 (8): 087113. arXiv: 2005.10357 . Bibcode:2020PhFl...32h7113D. doi:10.1063/5.0020565. PMC   7441410 . PMID   32848352.
  24. ↑ De-Leon H, Pederiva F (July 2021). "Statistical mechanics study of the introduction of a vaccine against COVID-19 disease". Physical Review E. 104 (1): 014132. arXiv: 2012.07306 . Bibcode:2021PhRvE.104a4132D. doi:10.1103/PhysRevE.104.014132. PMID   34412259. S2CID   229155979.
  25. ↑ "Dr. Ghaffarzadegan's model - Simulate your university's covid-19 cases". forio.com. Retrieved 2 May 2021.
  26. ↑ Ghaffarzadegan N (2021-02-01). "Simulation-based what-if analysis for controlling the spread of Covid-19 in universities". PLOS ONE. 16 (2): e0246323. Bibcode:2021PLoSO..1646323G. doi: 10.1371/journal.pone.0246323 . PMC   7850497 . PMID   33524045.
  27. ↑ "COVID-19 simulation model creates scenarios". www.vtnews.vt.edu. Archived from the original on 2021-03-06. Retrieved 2021-02-21.
  28. ↑ "Event Horizon - COVID-19". rocs.hu-berlin.de. Retrieved 14 December 2023.
  29. ↑ Maier BF, Brockmann D (May 2020). "Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China". Science. 368 (6492): 742–746. arXiv: 2002.07572 . Bibcode:2020Sci...368..742M. doi: 10.1126/science.abb4557 . PMC   7164388 . PMID   32269067.
  30. ↑ "Evolutionary AI". evolution.ml. Retrieved 14 December 2023.
  31. ↑ "Evolutionary AI". evolution.ml. Retrieved 2021-04-26.
  32. ↑ Miikkulainen R, Francon O, Meyerson E, Qiu X, Sargent D, Canzani E, Hodjat B (2020-08-01). "From Prediction to Prescription: Evolutionary Optimization of Non-Pharmaceutical Interventions in the COVID-19 Pandemic". arXiv: 2005.13766 [cs.NE].
  33. 1 2 "Can Computer Models Select the Best Public Health Interventions for COVID-19?". IEEE Spectrum: Technology, Engineering, and Science News. 5 January 2021. Retrieved 2021-04-26.
  34. ↑ Siwiak M, Szczesny P, Siwiak M (2020-07-10). "From the index case to global spread: the global mobility based modelling of the COVID-19 pandemic implies higher infection rate and lower detection ratio than current estimates". PeerJ. 8: e9548. doi: 10.7717/peerj.9548 . ISSN   2167-8359. PMID   32728498.
  35. ↑ Abele D, Kühn MJ, Koslow W, Rack K, Siggel M, Kleinert J, et al. (2022-01-01). "MEmilio - a high performance Modular EpideMIcs simuLatIOn software". GitHub.
  36. ↑ Kühn MJ, Abele D, Mitra T, Koslow W, Abedi M, Rack K, et al. (September 2021). "Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution". Mathematical Biosciences. 339: 108648. doi:10.1016/j.mbs.2021.108648. PMC   8243656 . PMID   34216635.
  37. ↑ Kühn MJ, Abele D, Binder S, Rack K, Klitz M, Kleinert J, Gilg J, Spataro L, Koslow W, Siggel M, Meyer-Hermann M, Basermann A (2022). "Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany". BMC Infectious Diseases. 22 (1): 333. doi: 10.1186/s12879-022-07302-9 . ISSN   1471-2334. medRxiv   10.1101/2021.04.23.21255995 . PMC   8978163 . PMID   35379190.
  38. ↑ Koslow W, Kühn MJ, Binder S, Klitz M, Abele D, Basermann A, Meyer-Hermann M (2022-05-16). "Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant". PLOS Computational Biology. 18 (5): e1010054. Bibcode:2022PLSCB..18E0054K. doi: 10.1371/journal.pcbi.1010054 . ISSN   1553-7358. medRxiv   10.1101/2021.07.09.21260257 . PMC   9135349 . PMID   35576211.
  39. ↑ Shattock AJ, Le Rutte EA, Dünner RP, Sen S, Kelly SL, Chitnis N, Penny MA (March 2022). "Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland". Epidemics. 38 (7): 100535. Bibcode:2021PLSCB..17E9146H. doi:10.1016/j.epidem.2021.100535. PMC   8669952 . PMID   34923396.
  40. ↑ "Git-repository with open access source-code for OpenCOVID". GitHub. Swiss TPH. 2022-01-31. Retrieved 2022-02-15.
  41. ↑ "COVID-19 Government Response Tracker". www.bsg.ox.ac.uk. 18 March 2020. Retrieved 14 December 2023.
  42. ↑ "COVID-19 Government Response Tracker". www.bsg.ox.ac.uk. 18 March 2020. Retrieved 2021-04-26.
  43. ↑ "sc-cosmo – Stanford-CIDE COronavirus Simulation MOdel" . Retrieved 14 December 2023.
  44. ↑ "SDL PAND - Mapa global". pand.sdlps.com. Retrieved 2023-05-20.
  45. ↑ Khailaie S, Mitra T, Bandyopadhyay A, Schips M, Mascheroni P, Vanella P, Lange B, Binder SC, Meyer-Hermann M (2021). "Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures". BMC Medicine. 19 (1): 32. doi: 10.1186/s12916-020-01884-4 . ISSN   1741-7015. medRxiv   10.1101/2020.04.04.20053637 . PMC   7840427 . PMID   33504336.
  46. ↑ "simm / covid19 / SECIR". GitLab. Retrieved 2021-07-05.
  47. ↑ "Report · Wiki · simm / covid19 / SECIR". GitLab. Retrieved 2021-07-05.
  48. ↑ "Our research". Helmholtz Centre for Infection Research. Retrieved 2021-07-05.
  49. ↑ Syga S, David-Rus D, Schälte Y, Hatzikirou H, Deutsch A (November 2021). "Inferring the effect of interventions on COVID-19 transmission networks". Scientific Reports. 11 (1): 21913. arXiv: 2012.03846 . Bibcode:2021NatSR..1121913S. doi:10.1038/s41598-021-01407-y. PMC   8578219 . PMID   34754025.
  50. ↑ "Epidemiology Collection". epubs.siam.org.
  51. ↑ Kastalskiy IA, Pankratova EV, Mirkes EM, Kazantsev VB, Gorban AN (November 2021). "Social stress drives the multi-wave dynamics of COVID-19 outbreaks". Scientific Reports. 11 (1): 22497. arXiv: 2106.08966 . Bibcode:2021NatSR..1122497K. doi: 10.1038/s41598-021-01317-z . PMC   8602246 . PMID   34795311.
  52. ↑ "COVID-19 Simulation Tool". corona-lab.ch. Retrieved 28 April 2021.
  53. ↑ Gorji H, Arnoldini M, Jenny DF, Hardt WD, Jenny P (2021-05-04). "Dynamic modelling to identify mitigation strategies for the COVID-19 pandemic". Swiss Medical Weekly. 151 (1718): w20487. doi:10.4414/smw.2021.20487. ISSN   1424-3997. medRxiv   10.1101/2020.11.30.20239566 . PMID   33945149.
  54. ↑ "CDC list of Forecast Inclusion and Assumptions". www.cdc.gov/coronavirus.
  55. ↑ "CORESMA". CORESMA. Retrieved 2021-07-05.
  56. ↑ "Home - COVID 19 forecast hub". covid19forecasthub.org. Retrieved 14 December 2023.
  57. ↑ Best R, Boice J (2020-05-01). "Where The Latest COVID-19 Models Think We're Headed — And Why They Disagree". FiveThirtyEight. Retrieved 2021-02-21.
  58. ↑ "Home - COVID 19 forecast hub". covid19forecasthub.org. Retrieved 2021-02-21.
  59. ↑ "Nextstrain". nextstrain.org. Retrieved 2021-04-26.
  60. ↑ "Nextstrain". nextstrain.org. Retrieved 14 December 2023.
  61. ↑ "SIMID – Simulation Models of Infectious Diseases" . Retrieved 14 December 2023.
  62. ↑ "Rapid Assistance in Modelling the Pandemic: RAMP | Royal Society". royalsociety.org. Retrieved 2021-03-09.
  63. ↑ "UT COVID-19 Modeling Consortium". covid-19.tacc.utexas.edu. Retrieved 14 December 2023.
  64. ↑ CDC (2020-02-11). "Coronavirus Disease 2019 (COVID-19) - COVID-19 Forecasting: Background Information". Centers for Disease Control and Prevention. Retrieved 2021-10-03.
  65. ↑ "About the Hub - COVID 19 forecast hub". covid19forecasthub.org. Retrieved 2021-10-03.
  66. ↑ "COVID-19 Map". Johns Hopkins Coronavirus Resource Center. Retrieved 14 December 2023.
  67. ↑ "COVID-19 Map". Johns Hopkins Coronavirus Resource Center. Retrieved 2021-04-26.
  68. ↑ Dong E, Du H, Gardner L (May 2020). "An interactive web-based dashboard to track COVID-19 in real time". The Lancet. Infectious Diseases. 20 (5): 533–534. doi:10.1016/S1473-3099(20)30120-1. PMC   7159018 . PMID   32087114.
  69. ↑ "COVIDVaxView | CDC". www.cdc.gov. 2021-09-23. Retrieved 2021-10-03.
  70. ↑ Datopian, Open Knowledge International. "Novel Coronavirus 2019". DataHub.io. Retrieved 2021-05-02.
  71. ↑ datasets/covid-19, Data Packaged Core Datasets at GitHub, 2021-05-02, retrieved 2021-05-02
  72. ↑ Bundesministerium für Gesundheit. "Das offizielle Dashboard zur Impfkampagne der Bundesrepublik Deutschland". impfdashboard.de (in German). Retrieved 2021-06-07.
  73. ↑ "Simulation der COVID19-Impfkampagne". www.zidatasciencelab.de. Retrieved 14 December 2023.
  74. ↑ "IHME | COVID-19 Projections". Institute for Health Metrics and Evaluation. Retrieved 14 December 2023.
  75. ↑ "Cellular Defense Automata model". thememeticist.github.io.
  76. ↑ "CoVariants (CoVariants] - Overview of SARS-CoV-2 variants and mutations that are of interest)". covariants.org. Retrieved 14 December 2023.
  77. ↑ "Covid-19 Simulator". www.coronasimulator.com. Retrieved 28 April 2021.
  78. ↑ Prabowo A (3 May 2020). "COVID19: Top 7 online interactive simulations, curated". Medium. Retrieved 2021-02-21.
  79. ↑ "Build software better, together (topics/covid-19)". GitHub. Retrieved 14 December 2023.
  80. ↑ "COVID-19 Simulator". exchange.iseesystems.com. Retrieved 14 December 2023.
  81. ↑ "Coronavirus Dashboard". ncov2019.live. Retrieved 14 December 2023.
  82. ↑ "cov19.cc" . Retrieved 18 August 2023.
  83. ↑ "COVID-19 Simulation Resources" . Retrieved 2020-02-21.
  84. ↑ "Simulating coronavirus with the SIR model". fatiherikli.github.io. Archived from the original on 2021-04-19. Retrieved 2021-02-21.
  85. ↑ "Covid-19 Spread Simulation". c19model.com. Retrieved 14 December 2023.
  86. ↑ "CAS COVID-19 Resources". CAS. Retrieved 2021-06-02.
  87. ↑ "COVID Data Tracker". Centers for Disease Control and Prevention. 28 March 2020. Retrieved 14 December 2023.
  88. ↑ "Full, live, global, COVID-19 Status Report for 251 locales & 71 Ships". civilsocietysolidarityagainstcovid19.com. Retrieved 2021-07-01.
  89. ↑ Bohan J. "LibGuides: Cornell Institute for Social & Economic Research (CISER): COVID-19 Data Sources". guides.library.cornell.edu. Retrieved 14 December 2023.
  90. ↑ Dbouk T, Drikakis D (January 2021). "On airborne virus transmission in elevators and confined spaces". Physics of Fluids. 33 (1): 011905. Bibcode:2021PhFl...33a1905D. doi:10.1063/5.0038180. PMC   7984422 . PMID   33790526.
  91. ↑ Larsen JR, Martin MR, Martin JD, Kuhn P, Hicks JB (2020). "Modeling the Onset of Symptoms of COVID-19". Frontiers in Public Health. 8: 473. doi: 10.3389/fpubh.2020.00473 . PMC   7438535 . PMID   32903584.
  92. ↑ Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, Macdonald B, Dattani S, Beltekian D, Ortiz-Ospina E, Roser M (5 March 2020). "Coronavirus Pandemic (COVID-19)". Our World in Data. Retrieved 14 December 2023.
  93. ↑ "The COVID Tracking Project". The COVID Tracking Project. Retrieved 14 December 2023.
  94. ↑ "Vadere – Open Source Framework for Pedestrian and Crowd Simulation". www.vadere.org. Retrieved 14 December 2023.
  95. ↑ "WHO Coronavirus (COVID-19) Dashboard". covid19.who.int. Retrieved 2021-07-01.

Further reading

Articles

Books

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.